tiprankstipranks
Trending News
More News >
Ryvu Therapeutics SA (PL:RVU)
:RVU
Poland Market
Advertisement

Ryvu Therapeutics SA (RVU) Technical Analysis

Compare
0 Followers

Summary of all the Indicators

Overall Consensus
Buy
14Bullish
3Neutral
5Bearish
Technical Analysis Consensus
Sell
2Bullish
3Neutral
5Bearish
Moving Average Consensus
Strong Buy
12Bullish
0Neutral
0Bearish
Ryvu Therapeutics SA’s (RVU) Moving Averages Convergence Divergence (MACD) indicator is 0.88, suggesting Ryvu Therapeutics SA is a Sell.
Ryvu Therapeutics SA’s (RVU) 20-Day exponential moving average is 26.30, while Ryvu Therapeutics SA’s (RVU) share price is zł28.7, making it a Buy.
Ryvu Therapeutics SA’s (RVU) 50-Day exponential moving average is 26.25, while Ryvu Therapeutics SA’s (RVU) share price is zł28.7, making it a Buy.

Ryvu Therapeutics SA (RVU) Pivot Points

Dec 04, 2025, 05:52 AM
Name
S3
S2
S1
Pivot Points
R1
R2
R3
Classic
27.03
27.37
28.03
28.37
29.03
29.37
30.03
Fibonacci
27.37
27.75
27.98
28.37
28.75
28.98
29.37
Pivot points are a technical analysis tool used by traders to identify potential support and resistance levels in financial markets. Pivot points are calculated based on the previous day's high, low, and close prices, and are used to help traders identify levels at which the price may reverse or continue to trend.

Ryvu Therapeutics SA (RVU) Moving Averages

Dec 04, 2025, 05:52 AM
Period
Simple
Exponential
MA5
28.48Buy
28.25Buy
MA10
26.81Buy
27.28Buy
MA20
25.37Buy
26.30Buy
MA50
25.92Buy
26.25Buy
MA100
27.69Buy
27.27Buy
MA200
28.03Buy
28.51Buy
Ryvu Therapeutics SA’s (RVU) 10-Day exponential moving average is 27.28, while Ryvu Therapeutics SA’s (RVU) share price is zł28.7, making it a Buy.
Ryvu Therapeutics SA’s (RVU) 100-Day exponential moving average is 27.27, while Ryvu Therapeutics SA’s (RVU) share price is zł28.7, making it a Buy.
Ryvu Therapeutics SA’s (RVU) stock price is zł28.7 and Ryvu Therapeutics SA’s (RVU) 50-day simple moving average is 25.92, creating a Buy signal.
Ryvu Therapeutics SA’s (RVU) stock price is zł28.7 and Ryvu Therapeutics SA’s (RVU) 100-day simple moving average is 27.69, creating a Buy signal.
Ryvu Therapeutics SA’s (RVU) stock price is zł28.7 and Ryvu Therapeutics SA’s (RVU) 200-day simple moving average is 28.03, creating a Buy signal.

Ryvu Therapeutics SA (RVU) Technical Indicators

Dec 04, 2025, 05:52 AM
Name
Value
Implied Action
RSI (14)
67.89
Neutral
STOCH (9,6)
90.06
Sell
STOCHRSI (14)
90.64
Sell
MACD (12,26)
0.88
Sell
ADX (14)
24.17
Neutral
Williams %R
-9.30
Sell
CCI (14)
138.12
Sell
ATR (14)
1.26
-
Ultimate Oscillator
66.85
Neutral
ROC
16.23
Buy
Ryvu Therapeutics SA’s (RVU) Relative Strength Index (RSI) is 67.89, creating a Neutral signal.
Ryvu Therapeutics SA’s (RVU) Trend Strength Indicator (ADX) is 24.17, creating a Neutral signal.
Ryvu Therapeutics SA’s (RVU) Commodity Channel Index (CCI) is 138.12, creating a Sell signal.
Ryvu Therapeutics SA’s (RVU) Price Rate of Change (ROC) is 16.23, creating a Buy signal.

FAQ

Is RVU a Buy, Hold, or Sell?
Based on RVU’s technical indicators, RVU is a Buy.
    What is RVU’s RSI (14)?
    RVU’s RSI (14) is 67.89, which suggests RVU is a Neutral.
      What is RVU’s MACD?
      RVU’s MACD is 0.88, which suggests RVU is a Sell.
        What is RVU’s 5-day moving average?
        RVU’s 5-day moving average is 28.48, which suggests RVU is a Buy.
          What is RVU’s 20-day moving average?
          RVU 20-day moving average is 25.37, which suggests RVU is a Buy.
            What is RVU’s 50-day moving average?
            RVU’s 50-day moving average is 25.92, which suggests RVU is a Buy.
              What is RVU’s 200-day moving average?
              RVU’s 200-day moving average is 28.03, which suggests RVU is a Buy.
                What is RVU’s Williams % R (14)?
                RVU’s Williams % R (14) is -9.30, which suggests RVU is a Sell.
                  What is RVU’s CCI (14)?
                  RVU’s CCI (14) is 138.12, which suggests RVU is a Sell.
                    What is the share price of Ryvu Therapeutics SA?
                    What am I Missing?
                    Make informed decisions based on Top Analysts' activity
                    Know what industry insiders are buying
                    Get actionable alerts from top Wall Street Analysts
                    Find out before anyone else which stock is going to shoot up
                    Get powerful stock screeners & detailed portfolio analysis